The cytokine balance in the maintenance of a persistent infection with Salmonella enterica serovar Typhimurium in mice

Cytokine

Volumn 33, Issue 4, 2006, Pages 212-218

  Sashinami, Hiroshi ^a   Yamamoto, Tomoko ^b   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

IFN ; IL 10; Salmonella enterica serovar Typhimurium; TGF ; TNF

Indexed keywords

CYTOKINE; ENDOPEPTIDASE CLPX; GAMMA INTERFERON; INTERLEUKIN 10; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENDOPEPTIDASE CLP; FEMALE; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 33646017749     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.02.002     Document Type: Article

References (61)

1. Galan J.E., and Curtiss III R. Distribution of the invA, -B, -C, and -D genes of Salmonella typhimurium among other Salmonella serovars: invA mutants of Salmonella typhi are deficient for entry into mammalian cells. Infect Immun 59 (1991) 2901-2908
2. Galan J.E., Ginocchio C., and Costeas P. Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J Bacteriol 174 (1992) 4338-4349
3. Cirillo D.M., Valdivia R.H., Monack D.M., and Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 30 (1998) 175-188
4. Groisman EA, Blank-Portard A-B, Uchiya K. Pathgenicity islands and the evolution of Salmonella virulence. In: Kaper JB, Hacker J, editors. Pathogenicity islands and other mobile virulence elements. Washington, DC: ASM Press, p. 127-50.
5. Hensel M., Shea J.E., Raupach B., Monack D., Falkow S., Gleeson C., et al. Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2. Mol Microbiol 24 (1997) 155-167
6. Hensel M., Shea J.E., Waterman S.R., Mundy R., Nikolaus T., Banks G., et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 30 (1998) 163-174
7. Ochman H., Soncini F.C., Solomon F., and Groisman E.A. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc Natl Acad Sci USA 93 (1996) 7800-7804
8. Shea J.E., Hensel M., Gleeson C., and Holden D.W. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA 93 (1996) 2593-2597
9. Buchmeier N.A., and Schreiber R.D. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 82 (1985) 7404-7408
10. Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158 (1983) 670-689
11. s) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J Immunol 156 (1996) 2894-2900
12. Eckmann L., and Kagnoff M.F. Cytokines in host defense against Salmonella. Microbes Infect 3 (2001) 1191-1200
13. Ramarathinam L., Shaban R.A., Niesel D.W., and Klimpel G.R. Interferon gamma (IFN-γ) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb Pathog 11 (1991) 347-356
14. Bao S., Beagley K.W., France M.P., Shen J., and Husband A.J. Interferon-γ plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 99 (2000) 464-472
15. Gulig P.A., Doyle T.J., Clare-Salzler M.J., Maiese R.L., and Matsui H. Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha. Infect Immun 65 (1997) 5191-5197
16. Nauciel C., and Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 60 (1992) 450-454
17. Matsumura H., Onozuka K., Terada Y., Nakano Y., and Nakano M. Effect of murine recombinant interferon-γ in the protection of mice against Salmonella. Int J Immunopharmacol 12 (1990) 49-56
18. Klimpel G.R., Asuncion M., Haithcoat J., and Niesel D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 63 (1995) 1134-1137
19. Moore K.W. O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 11 (1993) 165-190
20. Lee T.S., and Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8 (2002) 240-246
21. Riley J.K., Takeda K., Akira S., and Schreiber R.D. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 274 (1999) 16513-16521
22. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 174 (1991) 1549-1555
23. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90 (1993) 3725-3729
24. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., and Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178 (1993) 1041-1048
25. Arai T., Hiromatsu K., Nishimura H., Kimura Y., Kobayashi N., Ishida H., et al. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun 213 (1995) 600-607
26. Bermudez L.E., and Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 61 (1993) 3093-3097
27. Denis M., and Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 151 (1993) 5425-5430
28. Park D.R., and Skerrett S.J. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-γ: differential responses of blood monocytes and alveolar macrophages. J Immunol 157 (1996) 2528-2538
29. Flesch I.E., and Kaufmann S.H. Role of macrophages and αβ T lymphocytes in early interleukin 10 production during Listeria monocytogenes infection. Int Immunol 6 (1994) 463-468
30. Frei K., Nadal D., Pfister H.W., and Fontana A. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 178 (1993) 1255-1261
31. Chantry D., Turner M., Abney E., and Feldmann M. Modulation of cytokine production by transforming growth factor-beta. J Immunol 142 (1989) 4295-4300
32. Redini F., Mauviel A., Pronost S., Loyau G., and Pujol J.P. Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 36 (1993) 44-50
33. Wahl S.M., Costa G.L., Corcoran M., Wahl L.M., and Berger A.E. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 150 (1993) 3553-3560
34. Galdiero M., Marcatili A., Cipollaro de l'Ero G., Nuzzo I., Bentivoglio C., and Romano Carratelli C. Effect of transforming growth factor β on experimental Salmonella typhimurium infection in mice. Infect Immun 67 (1999) 1432-1438
35. Chatfield S.N., Strahan K., Pickard D., Charles I.G., Hormaeche C.E., and Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog 12 (1992) 145-151
36. Dorman C.J., Chatfield S., Higgins C.F., Hayward C., and Dougan G. Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect Immun 57 (1989) 2136-2140
37. O'Callaghan D., Maskell D., Liew F.Y., Easmon C.S., and Dougan G. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun 56 (1988) 419-423
38. Sukupolvi S., Edelstein A., Rhen M., Normark S.J., and Pfeifer J.D. Development of a murine model of chronic Salmonella infection. Infect Immun 65 (1997) 838-842
39. Sydenham M., Douce G., Bowe F., Ahmed S., Chatfield S., and Dougan G. Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines. Infect Immun 68 (2000) 1109-1115
40. Frees D., and Ingmer H. ClpP participates in the degradation of misfolded protein in Lactococcus lactis. Mol Microbiol 31 (1999) 79-87
41. Frees D., Qazi S.N., Hill P.J., and Ingmer H. Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 48 (2003) 1565-1578
42. Gaillot O., Pellegrini E., Bregenholt S., Nair S., and Berche P. The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes. Mol Microbiol 35 (2000) 1286-1294
43. Maurizi M.R. Proteases and protein degradation in Escherichia coli. Experientia 48 (1992) 178-201
44. Msadek T., Dartois V., Kunst F., Herbaud M.L., Denizot F., and Rapoport G. ClpP of Bacillus subtilis is required for competence development, motility, degradative enzyme synthesis, growth at high temperature and sporulation. Mol Microbiol 27 (1998) 899-914
45. Volker U., Engelmann S., Maul B., Riethdorf S., Volker A., Schmid R., et al. Analysis of the induction of general stress proteins of Bacillus subtilis. Microbiology 140 Pt 4 (1994) 741-752
46. Yamamoto T., Sashinami H., Takaya A., Tomoyasu T., Matsui H., Kikuchi Y., et al. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha. Infect Immun 69 (2001) 3164-3174
47. Gulig P.A., and Curtiss III R. Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 55 (1987) 2891-2901
48. Nakane A., Nishikawa S., Sasaki S., Miura T., Asano M., Kohanawa M., et al. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in interferon-gamma depleted mice. Infect Immun 64 (1996) 1252-1258
49. Nakane A., Okamoto M., Asano M., Kohanawa M., and Minagawa T. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun 63 (1995) 1165-1172
50. Spitalny G.L., and Havell E.A. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 159 (1984) 1560-1565
51. Abrams J.S., Roncarolo M.G., Yssel H., Andersson U., Gleich G.J., and Silver J.E. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127 (1992) 5-24
52. Mosmann T.R., Schumacher J.H., Fiorentino D.F., Leverah J., Moore K.W., and Bond M.W. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J Immunol 145 (1990) 2938-2945
53. Schafer R., and Eisenstein T.K. Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect Immun 60 (1992) 791-797
54. Pie S., Truffa-Bachi P., Pla M., and Nauciel C. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect Immun 65 (1997) 4509-4514
55. + TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J Immunol 156 (1996) 3321-3326
56. +/+ mice and can be reactivated by IFN-γ neutralization. J Exp Med 199 (2004) 231-241
57. Muotiala A., and Makela P.H. The role of IFN-γ in murine Salmonella typhimurium infection. Microb Pathog 8 (1990) 135-141
58. Kirby A.C., Yrlid U., Svensson M., and Wick M.J. Differential involvement of dendritic cell subsets during acute Salmonella infection. J Immunol 166 (2001) 6802-6811
59. Mastroeni P., Skepper J.N., and Hormaeche C.E. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 63 (1995) 3674-3682
60. Li Q., Sun B., Dastgheib K., and Chan C.C. Suppressive effect of transforming growth factor beta1 on the recurrence of experimental melanin protein-induced uveitis: upregulation of ocular interleukin-10. Clin Immunol Immunopathol 81 (1996) 55-61
61. Perrella M.A., Hsieh C.M., Lee W.S., Shieh S., Tsai J.C., Patterson C., et al. Arrest of endotoxin-induced hypotension by transforming growth factor β1. Proc Natl Acad Sci USA 93 (1996) 2054-2059